0001178913-20-001753.txt : 20200608 0001178913-20-001753.hdr.sgml : 20200608 20200608060626 ACCESSION NUMBER: 0001178913-20-001753 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200512 FILED AS OF DATE: 20200608 DATE AS OF CHANGE: 20200608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harel Insurance Co LTD CENTRAL INDEX KEY: 0001666482 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39279 FILM NUMBER: 20948030 BUSINESS ADDRESS: STREET 1: ABBA HILLEL 3 CITY: RAMAT GAN STATE: L3 ZIP: 5211802 BUSINESS PHONE: 97237547090 MAIL ADDRESS: STREET 1: ABBA HILLEL 3 CITY: RAMAT GAN STATE: L3 ZIP: 5211802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harel Insurance Investments & Financial Services Ltd. CENTRAL INDEX KEY: 0001429390 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39279 FILM NUMBER: 20948031 BUSINESS ADDRESS: STREET 1: HAREL HOUSE, 3 ABBA HILLEL ST. CITY: RAMAT GAN STATE: L3 ZIP: 52118 BUSINESS PHONE: 972-3-7547090 MAIL ADDRESS: STREET 1: HAREL HOUSE, 3 ABBA HILLEL ST. CITY: RAMAT GAN STATE: L3 ZIP: 52118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001797336 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823578375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: (857) 444-0553 MAIL ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 4/A 1 ownership.xml X0306 4/A 2020-05-12 2020-05-14 0 0001797336 Ayala Pharmaceuticals, Inc. AYLA 0001666482 Harel Insurance Co LTD 3 ABA HILLEL ROAD STREET RAMAT GAN L3 52118 ISRAEL 0 0 1 0 0001429390 Harel Insurance Investments & Financial Services Ltd. 3 ABA HILLEL ROAD STREET RAMAT GAN L3 52118 ISRAEL 0 0 1 0 Common Stock, par value $0.01 per share 1663834 I See footnotes On May 14, 2020, Harel Insurance Investments & Financial Services Ltd. ("Harel Holdings") and Harel Insurance Company Ltd., a wholly owned subsidiary of Harel Holdings ("Harel Insurance" and, together with Harel Holdings, the "Reporting Persons"), filed a Form 4 (the "Form 4"). The Form 4 inadvertently reported the purchase of 500,000 shares of Common Stock of the Issuer that, as described in footnote 4 to the Form 4, were acquired and are held for members of the public through, among others, provident funds and/or mutual funds and/or pension funds and/or insurance policies and/or exchange traded funds (together, the "Public Shares"), which Public Shares are managed by wholly owned subsidiaries of the Reporting Persons, each of which subsidiaries operates under independent management and makes independent voting and investment decisions. Continued from Footnote (1): In accordance with Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended, the Reporting Persons do not have any direct or indirect pecuniary interest in the Public Shares or any transactions therein. Accordingly, this amendment to the Form 4 is being made to correct that inadvertent error by removing the purchase of the 500,000 Public Shares from the Form 4. As a result, and after giving effect to this amendment, the correct amount of shares of Common Stock of the Issuer beneficially owned by the Reporting Persons is 1,663,834 shares. Pursuant to Instruction 9 to Form 4, the Reporting Persons have omitted from this amendment to the Form 4 the transaction information with respect to the other shares of the Issuer that were reported in the initial filing of the Form 4 and which are not being amended hereby. HAREL INSURANCE COMPANY LTD. BY: /s/ Uri Rabinovitz, Vice President 2020-06-08 HAREL INSURANCE INVESTMENTS AND FINANCIAL SERVICES LTD. BY: /s/ Uri Rabinovitz, Vice President 2020-06-08